Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Nectar Lifesciences Limited (NSE: NECLIFE), ISIN INE023H01027 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
NECLIFE last traded at ₹10.23 (-0.49%), with a 52-week range of ₹9.30 to ₹22.40 (as of 6 Nov 2026).
Shareholding as of Sep 2026: promoters 51.84%, FIIs 0.50%, DIIs 0.00%, mutual funds 0.00%.
EquiSense Score (ECS): 11/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.